カテゴリー： QYResearch, 世界, 医療/バイオ

世界の創薬向け人工知能（AI）市場インサイト及び予測（ハードウェア、ソフトウェア）

◆英語タイトル：Global Artificial Intelligence (AI) in Pharmaceutical Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09228 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：110 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、創薬向け人工知能（AI）のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に創薬向け人工知能（AI）の世界市場のxxx％を占める「ハードウェア」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬会社」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
創薬向け人工知能（AI）の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの創薬向け人工知能（AI）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

創薬向け人工知能（AI）のグローバル主要企業には、AstraZeneca LLC、Atomwise Inc、Bayer AG、Cloud Pharmaceuticals Inc、GNS Healthcare、IBM Watson、Merck & Co.、Microsoft Corporation、Novartis AG、NVIDIA Corporation、Pfizer Inc.、Recursion Pharmaceuticals Inc.、XtalPi Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

創薬向け人工知能（AI）市場は、種類と用途によって区分されます。世界の創薬向け人工知能（AI）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ハードウェア、ソフトウェア

【用途別セグメント】
製薬会社、生物学研究所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 創薬向け人工知能（AI）製品概要
- 種類別市場（ハードウェア、ソフトウェア）
- 用途別市場（製薬会社、生物学研究所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の創薬向け人工知能（AI）販売量予測2017-2028
- 世界の創薬向け人工知能（AI）売上予測2017-2028
- 創薬向け人工知能（AI）の地域別販売量
- 創薬向け人工知能（AI）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別創薬向け人工知能（AI）販売量
- 主要メーカー別創薬向け人工知能（AI）売上
- 主要メーカー別創薬向け人工知能（AI）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ハードウェア、ソフトウェア）
- 創薬向け人工知能（AI）の種類別販売量
- 創薬向け人工知能（AI）の種類別売上
- 創薬向け人工知能（AI）の種類別価格
・用途別市場規模（製薬会社、生物学研究所、その他）
- 創薬向け人工知能（AI）の用途別販売量
- 創薬向け人工知能（AI）の用途別売上
- 創薬向け人工知能（AI）の用途別価格
・北米市場
- 北米の創薬向け人工知能（AI）市場規模（種類別、用途別）
- 主要国別の創薬向け人工知能（AI）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの創薬向け人工知能（AI）市場規模（種類別、用途別）
- 主要国別の創薬向け人工知能（AI）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の創薬向け人工知能（AI）市場規模（種類別、用途別）
- 主要国別の創薬向け人工知能（AI）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の創薬向け人工知能（AI）市場規模（種類別、用途別）
- 主要国別の創薬向け人工知能（AI）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの創薬向け人工知能（AI）市場規模（種類別、用途別）
- 主要国別の創薬向け人工知能（AI）市場規模（トルコ、サウジアラビア）
・企業情報
AstraZeneca LLC、Atomwise Inc、Bayer AG、Cloud Pharmaceuticals Inc、GNS Healthcare、IBM Watson、Merck & Co.、Microsoft Corporation、Novartis AG、NVIDIA Corporation、Pfizer Inc.、Recursion Pharmaceuticals Inc.、XtalPi Inc
・産業チェーン及び販売チャネル分析
- 創薬向け人工知能（AI）の産業チェーン分析
- 創薬向け人工知能（AI）の原材料
- 創薬向け人工知能（AI）の生産プロセス
- 創薬向け人工知能（AI）の販売及びマーケティング
- 創薬向け人工知能（AI）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 創薬向け人工知能（AI）の産業動向
- 創薬向け人工知能（AI）のマーケットドライバー
- 創薬向け人工知能（AI）の課題
- 創薬向け人工知能（AI）の阻害要因
・主な調査結果

Market Analysis and Insights: Global Artificial Intelligence (AI) in Pharmaceutical Market
The global Artificial Intelligence (AI) in Pharmaceutical market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Hardware accounting for % of the Artificial Intelligence (AI) in Pharmaceutical global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical Company segment is altered to an % CAGR throughout this forecast period.
China Artificial Intelligence (AI) in Pharmaceutical market size is valued at US$ million in 2021, while the North America and Europe Artificial Intelligence (AI) in Pharmaceutical are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Artificial Intelligence (AI) in Pharmaceutical landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artificial Intelligence (AI) in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artificial Intelligence (AI) in Pharmaceutical market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Intelligence (AI) in Pharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Intelligence (AI) in Pharmaceutical market.
Global Artificial Intelligence (AI) in Pharmaceutical Scope and Market Size
Artificial Intelligence (AI) in Pharmaceutical market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence (AI) in Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hardware
Software
Segment by Application
Pharmaceutical Company
Institute of Biology
Others
By Company
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Company
1.3.3 Institute of Biology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Perspective (2017-2028)
2.2 Artificial Intelligence (AI) in Pharmaceutical Growth Trends by Region
2.2.1 Artificial Intelligence (AI) in Pharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Region (2017-2022)
2.2.3 Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Region (2023-2028)
2.3 Artificial Intelligence (AI) in Pharmaceutical Market Dynamics
2.3.1 Artificial Intelligence (AI) in Pharmaceutical Industry Trends
2.3.2 Artificial Intelligence (AI) in Pharmaceutical Market Drivers
2.3.3 Artificial Intelligence (AI) in Pharmaceutical Market Challenges
2.3.4 Artificial Intelligence (AI) in Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Revenue (2017-2022)
3.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Players (2017-2022)
3.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence (AI) in Pharmaceutical Revenue
3.4 Global Artificial Intelligence (AI) in Pharmaceutical Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2021
3.5 Artificial Intelligence (AI) in Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence (AI) in Pharmaceutical Product Solution and Service
3.7 Date of Enter into Artificial Intelligence (AI) in Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Pharmaceutical Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Type (2017-2022)
4.2 Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Type (2023-2028)
5 Artificial Intelligence (AI) in Pharmaceutical Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Application (2017-2022)
5.2 Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Artificial Intelligence (AI) in Pharmaceutical Market Size (2017-2028)
6.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Type
6.2.1 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2017-2022)
6.2.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2023-2028)
6.2.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Share by Type (2017-2028)
6.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
6.3.1 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2017-2022)
6.3.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2023-2028)
6.3.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2017-2028)
6.4 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
6.4.1 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2017-2022)
6.4.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size (2017-2028)
7.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Type
7.2.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2017-2022)
7.2.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2023-2028)
7.2.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Share by Type (2017-2028)
7.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
7.3.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2017-2022)
7.3.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2023-2028)
7.3.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2017-2028)
7.4 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
7.4.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2017-2022)
7.4.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size (2017-2028)
8.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Type
8.2.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Share by Type (2017-2028)
8.3 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
8.3.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2017-2028)
8.4 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region
8.4.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size (2017-2028)
9.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Type
9.2.1 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2017-2022)
9.2.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2023-2028)
9.2.3 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Share by Type (2017-2028)
9.3 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
9.3.1 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2017-2022)
9.3.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2023-2028)
9.3.3 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2017-2028)
9.4 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
9.4.1 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2017-2022)
9.4.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size (2017-2028)
10.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Type
10.2.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Share by Type (2017-2028)
10.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
10.3.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2017-2028)
10.4 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country
10.4.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca LLC
11.1.1 AstraZeneca LLC Company Details
11.1.2 AstraZeneca LLC Business Overview
11.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Introduction
11.1.4 AstraZeneca LLC Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.1.5 AstraZeneca LLC Recent Developments
11.2 Atomwise Inc
11.2.1 Atomwise Inc Company Details
11.2.2 Atomwise Inc Business Overview
11.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.2.4 Atomwise Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.2.5 Atomwise Inc Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Introduction
11.3.4 Bayer AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.3.5 Bayer AG Recent Developments
11.4 Cloud Pharmaceuticals Inc
11.4.1 Cloud Pharmaceuticals Inc Company Details
11.4.2 Cloud Pharmaceuticals Inc Business Overview
11.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.4.4 Cloud Pharmaceuticals Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.4.5 Cloud Pharmaceuticals Inc Recent Developments
11.5 GNS Healthcare
11.5.1 GNS Healthcare Company Details
11.5.2 GNS Healthcare Business Overview
11.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Introduction
11.5.4 GNS Healthcare Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.5.5 GNS Healthcare Recent Developments
11.6 IBM Watson
11.6.1 IBM Watson Company Details
11.6.2 IBM Watson Business Overview
11.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Introduction
11.6.4 IBM Watson Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.6.5 IBM Watson Recent Developments
11.7 Merck & Co.
11.7.1 Merck & Co. Company Details
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.7.4 Merck & Co. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.7.5 Merck & Co. Recent Developments
11.8 Microsoft Corporation
11.8.1 Microsoft Corporation Company Details
11.8.2 Microsoft Corporation Business Overview
11.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Introduction
11.8.4 Microsoft Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.8.5 Microsoft Corporation Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Introduction
11.9.4 Novartis AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.9.5 Novartis AG Recent Developments
11.10 NVIDIA Corporation
11.10.1 NVIDIA Corporation Company Details
11.10.2 NVIDIA Corporation Business Overview
11.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Introduction
11.10.4 NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.10.5 NVIDIA Corporation Recent Developments
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Company Details
11.11.2 Pfizer Inc. Business Overview
11.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.11.4 Pfizer Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.11.5 Pfizer Inc. Recent Developments
11.12 Recursion Pharmaceuticals Inc.
11.12.1 Recursion Pharmaceuticals Inc. Company Details
11.12.2 Recursion Pharmaceuticals Inc. Business Overview
11.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.12.4 Recursion Pharmaceuticals Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.12.5 Recursion Pharmaceuticals Inc. Recent Developments
11.13 XtalPi Inc
11.13.1 XtalPi Inc Company Details
11.13.2 XtalPi Inc Business Overview
11.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.13.4 XtalPi Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2017-2022)
11.13.5 XtalPi Inc Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の創薬向け人工知能（AI）市場インサイト及び予測（ハードウェア、ソフトウェア）(Global Artificial Intelligence (AI) in Pharmaceutical Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の創薬向け人工知能（AI）市場インサイト及び予測（ハードウェア、ソフトウェア）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp